,PD-L1 (SP263)

Xiaopeng Zhuang1, Huiting Li2, Zhijie You1

  • 1Department of Pathology, The Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.

PubMed
概括

前列腺癌中的PD-L1 (SP263) 表达与高格里森群和高级阶段等侵略性特征相关. 这表明PD-L1可能有助于分层风险,并指导涉及p53抑制剂和PD-1/PD-L1抗体的联合疗法.